|Table of Contents|

Survival analysis of lung cancer patients in Shijiazhuang city

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 04
Page:
752-755
Research Field:
Publishing date:

Info

Title:
Survival analysis of lung cancer patients in Shijiazhuang city
Author(s):
DANG Jing; MA Xinyan; ZHAI Shiyong; GAO Cong; ZHANG Yulan
Shijiazhuang Center for Disease Control and Prevention，Hebei Shijiazhuang 050011，China．
Keywords:
lung cancer; survival rate; follow-up; influence factor
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2023.04.030
Abstract:
Objective:To study the survival state of lung cancer patients in Shijiazhuang city.Methods:Lung cancer patients diagnosed in Shijiazhuang in 2015 were followed up to December 31,2020.Survival rate and median survival time were calculated by life table method,and were tested by log-rank test.Cox regression analysis was used in the multivariate analysis.Results:All 1 537 cases of lung cancer were included in the study.The average age of patients was(66.80±11.46)years.The overall median survival time was 15.60 months.The 1-year,3-year,and 5-year survival rates were 55.05%,38.25%，27.39%.The survival rates were different with gender,area,age,TNM stage,histological type.The 5-year survival rates of male(21.99%),rural(12.23%)and small cell carcinoma(13.49%)was lower than that of female(31.99%),urban(33.68%)and adenocarcinoma(40.06%),survival rates decreased with the increasing of age and TNM stage.In Cox regression analysis,gender,area,histological type,TNM stage were independent prognostic factors.Histological type and TNM stage and greater influence on survival.Conclusion:The prognosis of lung cancer generally is poor.In different regions,screening mechanisms and health education should be strengthened for different people.Early prevention,early screening,early diagnosis and early treatment are helpful to prolong the survival time of lung cancer patients.

References:

［1］高从，马新颜，董会敏.2016年石家庄市肿瘤登记地区恶性肿瘤发病与死亡分析［J］.肿瘤防治研究,2020,47（7）：547-552. GAO C,MA XY,DONG HM.Incidence and mortality of cancer in Shijiazhuang cancer registries,2016［J］.Cancer Res Prev Treat,2020,47（7）：547-552.
［2］罗胜兰.浙江省常见恶性肿瘤生存分析［D］.宁波：宁波大学，2014． LUO SL.Survival analysis of common cancers in Zhejiang province［D］.Ningbo：Ningbo University,2014.
［3］何美,李必波,杜佳,等.2001-2018 年重庆市肺癌患者临床特征及生存分析［J］.中国肿瘤,2020,29(11):865-870. HE M,LI BB,DU J,et al.Clinical characteristics and survival of lung cancer patients in chongqing,2001-2018［J］.China Cancer,2020,29(11):865-870.
［4］王媛媛,毕玉,王在翔,等.山东省肺癌患者生存分析［J］.中国卫生统计,2018,35(1):111-113,116. WANG YY,BI Y,WANG ZX,et al.Survival analysis of lung cancer patients in Shandong province［J］.Chinese Health statistics,2018,35(1):111-113,116.
［5］吴新凡，王临池，张秋,等.苏州市姑苏区2008-2013 年恶性肿瘤患者生存分析［J］.中国初级卫生保健,2021,35(3):41-44. WU XF,WANG LC,ZHANG Q,et al.Survival of cancer patients in Gusu district of Suzhou［J］.Chinese Primary Health Care，2021，35（3）：41-44.
［6］VARLOTTO JM，YAO AN，DE CAMP MM，et al.Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival［J］.Int J Ｒadiat Oncol Biol Phys,2015,91(4):765-772．
［7］YANG CJ，GU L，SHAH SA，et al.Long-term outcomes of surgical resection for stage Ⅳ non-small-cell lung cancer:A national analysis［J］.Lung Cancer,2018,115:75-83.
［8］段桦，胡凯文，崔慧娟,等.108例老年晚期非小细胞肺癌患者预后因素分析［J］.癌症进展,2020,18（5）:470-474. DUAN H，HU KW，CUI HJ，et al.Multivariate analysis of prognostic factors in the elderly patients with advanced non-small cell lung cancer:A study of 108 patients［J］.Oncology Progress,2020,18(5):470-474.
［9］JIANG W，KANG Y，SHI GY，et al.Comparisons of multiple characteristics between young and old lung cancer patients［J］.Chin Med J（Engl），2012,125(1):72-80.
［10］俞婷婷,李应龙,王若峥.558例维吾尔族肺癌患者的临床病理特征及预后分析［J］.肿瘤防治研究,2018,45(7)：494-499. YU TT,LI YL,WANG RZ.Clinic pathological characteristics and prognosis of Uygur lung cancer patients:A report of 558 cases［J］.Cancer Res Treat,2018,45(7):494-499.
［11］李继华,何俊,张云生,等.云南宣威富源地区非吸烟女性肺癌生存分析［J］.中国肺癌杂志,2019,22(8):477-486. LI JH，HE J，ZHANG YS，et al.Survival in lung cancer among female never-smokers in rural Xuanwei and Fuyuan counties in eastern Yunnan province［J］.Chinese Lung Cancer,2019,22(8):477-486.
［12］陈国标,杜巍,周建平,等.肺癌病例分布及病例特征趋势分析［J］中华肺部疾病杂志,2021,14（05）:590-592. CHEN GB,DU W,ZHOU JP,et al.Analysis on the trend of lung cancer case distribution and pathological features［J］Chinese Journal of Lung Diseases,2021,14(05):590-592.
［13］HANAGIRI T,SUGIO K,URAMOTO H,et al.Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer［J］.Surgery Today,2007,37(7):546-551．
［14］于正伦,张曙光,张其刚,等.影响肺癌手术患者生存因素研究［J］.中国卫生统计,2016,33(3):466-467． YU ZL,ZHANG SG,ZHANG QG,et al.Factors influencing survival of patients undergoing lung cancer surgery［J］.Chinese Health Statistics,2016,33(3):466-467．
［15］冯素青,郭建花.石家庄市12320卫生热线服务人群吸烟状况调查［J］.中国慢性病预防与控制,2015,53(4):282-285. FENG SQ,GUO JH.Investigation on smoking status of 12320 health hotline service population in Shijiazhuang city［J］.Chin J Prev Contr Chron Dis,2015,53(4):282-285.
［16］丁凡，曾果.低剂量螺旋CT对早期肺癌的诊断价值［J］.现代诊断与治疗,2021,32（4）:614-615. DING F,ZENG G.Diagnostic value of low dose spiral CT in early lung cancer［J］.Mod Diagn Treat,2021,32（4）:614-615.
［17］管雅喆,任萌,郭冬利,等.肺癌筛查研究进展［J］.中国肺癌杂志,2020,23(11):954-960. GUAN YZ,REN M,GUO DL,et al.Research progression lung cancer screening［J］.Chinese Lung Cancer,2020,23(11):954-960.
［18］PASTORINO U,SILVA M,SESTINI S,et al.Prolonged lung cancer screening reduced 10-year mortality in the MILD trial:New confirmation of lung cancer screening efficacy［J］.Ann Oncol,2019,30(7):1162-1169.
［19］DE ANGELIS R,SANT M,COLEMAN MP,et al.Cancer survival in Europe 1999-2007 by country and age:Results of EUROCARE-5-a population based study［J］.Lancet Oncol,2014,15(1):23-24.

Memo

Memo:
-
Last Update: 1900-01-01